4
Changes in Ownership
NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-087937
Chief Operating Officer sold 100,000 shares at an average $19.29 ($1,929,141)
- Chief Operating Officer acquired 100,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kling Douglas F Chief Operating Officer | 2025-06-16 | Option exercise 10b5-1 | +78,101 | $10.00 | $781,010 | 122,101 | D: show line 1 in the form |
| Kling Douglas F Chief Operating Officer | 2025-06-16 | Option exercise 10b5-1 | +21,899 | $10.90 | $238,699 | 144,000 | D: show line 2 in the form |
| Kling Douglas F Chief Operating Officer | 2025-06-16 | Sale 10b5-1 | −81,891 | $19.19 | $1,571,488 | 62,109 | D: show line 3 in the form |
| Kling Douglas F Chief Operating Officer | 2025-06-16 | Sale 10b5-1 | −18,109 | $19.75 | $357,653 | 44,000 | D: show line 4 in the form |
| Open-market sales · 100,000 sh · avg $19.29 · $1,929,141 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kling Douglas F Chief Operating Officer | 2025-06-16 | Option exercise · Option (right to buy) 10b5-1 | −78,101 | 372,829 | D: show line 5 in the form | |||||
| Kling Douglas F Chief Operating Officer | 2025-06-16 | Option exercise · Option (right to buy) 10b5-1 | −21,899 | 261,314 | D: show line 6 in the form |
Loading xslF345X05/ownership.xml…